Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
Clinical trial NCT00126412 · COMPLETED
Trial details
- NCT number
- NCT00126412
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-02
- Primary completion
- 2006-09-27
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.